The short version.
If you read nothing else, read this. The whole guide in a handful of bullets.
- What it is: PT-141 (bremelanotide) is a synthetic melanocortin peptide. It is the same molecule as the FDA-approved drug Vyleesi, sold here as a research-grade vial.
- What people run it for: raising sexual desire and arousal in both men and women, taken before intimacy on an as-needed basis.
- Typical dose: around 1 to 2 mg subcutaneously, about 45 minutes before intimacy. The approved Vyleesi dose is 1.75 mg.
- Routes: subcutaneous injection is the standard. An intranasal spray exists, but nasal trials were halted years ago over blood pressure spikes.
- Frequency: as-needed, not daily. No more than one dose in 24 hours, and a common ceiling of about eight doses a month.
- Honest caveat: the strong human evidence is on the approved drug in premenopausal women. Use in men and the research vials sit outside that label. It is sold for research use only, and this is not medical advice.
Quick reference.
| Typical dose | 1 to 2 mg, ~45 minutes before intimacy |
|---|---|
| Routes | Subcutaneous injection (standard), intranasal (largely abandoned) |
| Frequency | As-needed, max one dose per 24 hours |
| Onset | ~45 minutes to 2 hours, lasting several hours |
| Best for | Low sexual desire and arousal, in men and women |
What is PT-141?
PT-141 is a short peptide, which simply means a small chain of amino acids, the same building blocks that make up the proteins in your body. Its proper name is bremelanotide, and it belongs to a family called melanocortin agonists.
It started life as a spin-off of Melanotan II, the tanning peptide. Researchers noticed that Melanotan II also raised sexual arousal, so they refined the molecule to keep the libido effect, and PT-141 is the result. In 2019 the subcutaneous version was approved by the FDA as Vyleesi for premenopausal women with low sexual desire.
The version sold by research vendors arrives as a freeze-dried white powder in a small sealed vial. It is not a steroid, not a hormone in the testosterone sense, and not a blood-flow drug like Viagra. People reach for it for one theme above all: it is studied for raising desire itself, working in the brain rather than the plumbing.
Worth saying plainly: the research-grade vial is not the approved medicine, even though it is the same molecule. It is sold strictly for research use only, and the strongest human evidence is in premenopausal women, not men. We get into what that means further down.
How it works in the body.
You do not need a biology degree to follow this. Here is the simple picture, then a little more for the curious.
The core idea is that PT-141 works in the brain, not the bloodstream. It switches on receptors tied to arousal and desire, which is a genuinely different approach from the blood-flow drugs most people know.
- Melanocortin receptors. PT-141 activates the MC3R and MC4R receptors, which sit in the central nervous system on pathways linked to sexual arousal and reward. This is the heart of how it works.
- Dopamine signaling. By acting on those pathways it is studied for nudging dopamine release in arousal-related regions of the brain, which is associated with a rise in desire.
- Central, not vascular. Unlike sildenafil or tadalafil, which act on blood vessels, PT-141 acts centrally. That is why it is studied for low desire rather than purely mechanical function, and why it can apply to both men and women.
How to take it: routes of administration.
PT-141 is primarily an injectable peptide. There is also a nasal spray form floating around the research world, but its history matters, so here is the honest comparison.
| Route | Typical dose | Absorption | Best for | Difficulty |
|---|---|---|---|---|
| Subcutaneous | 1 to 2 mg | Reliable, predictable | The standard route | Tiny needle, FDA-approved form |
| Intranasal | Varies | Fast but erratic | Largely abandoned | Nasal trials halted over blood pressure |
| Oral | Not practical | Very low | Not recommended | Poorly absorbed |
Subcutaneous injection
The standard route by far, and the one the approved Vyleesi pen uses. A tiny insulin needle goes into the fat just under the skin, about 45 minutes before intimacy. It is far less intimidating than it sounds and gives predictable timing.
Intranasal
An early form of PT-141 was a nasal spray, and it worked quickly. But the FDA halted intranasal research years ago over spikes in blood pressure, so it never reached approval. Compounded nasal versions still exist, but the safety question is why most people stick to subcutaneous.
Oral
PT-141 is a peptide that does not survive digestion well, so it is not a practical oral option. There are no meaningful oral capsule versions worth chasing. Stick to the injectable form.
Where to inject.
If you go this route, these are the sites people use. Rotate so no single area gets sore.
The easiest spots are the belly (about 2 inches either side of the navel), the love handles, the front of the thigh, and the back of the upper arms. Rotate every injection.
So which should someone pick? For almost everyone, subcutaneous is the answer: it is the approved route, the needle is tiny, and the timing is predictable. The nasal form may sound easier, but the blood pressure concerns that ended its development are a real reason to be cautious, so it is not the default.
Reconstitution: mixing it.
PT-141 arrives as a dry powder, so before you can inject it you reconstitute it, which just means adding liquid to turn the powder into something you can draw into a syringe. It sounds technical but takes about a minute.
Once it is mixed, the only real question is how many units to draw. That depends on your vial size, your water amount, and your target dose, and it is easy to get wrong by hand.
- Use bacteriostatic water, often called BAC water. The small amount of preservative keeps the mixed vial usable for weeks.
- Add the water slowly, down the inside wall of the vial. A common mix is a 10 mg vial plus 2 mL of BAC water, which gives a concentration of 5 mg/mL.
- Swirl, do not shake. Gently roll the vial until the powder dissolves. Shaking can damage the peptide.
- Store it in the fridge once mixed, and keep it out of direct light.
Open the dosage calculator to turn your vial and dose into an exact number of units. As a worked example: a 10 mg vial mixed with 2 mL of BAC water gives 5 mg/mL, so a 1 mg dose is 0.2 mL, which is 20 units on a U-100 insulin syringe, and that vial holds about 10 doses.
Dosing by goal.
There is no single official research dose for PT-141, because the research vial is not an approved medicine. What follows is the range people commonly run, anchored to the approved drug. The defining feature of PT-141 dosing is that it is taken before intimacy, not on a daily schedule.
Starting dose
Because nausea is common, many people start low, around 0.5 mg, to see how they tolerate it. This first dose is as much about gauging your stomach as about effect.
Standard dose
The common range is about 1 to 2 mg taken roughly 45 minutes before intimacy. The approved Vyleesi dose is 1.75 mg, which sits right in that band. People rarely need to push past 2 mg.
Frequency and ceiling
PT-141 is used as-needed, not daily. The widely followed limits, taken from the approved label, are no more than one dose in any 24 hours and no more than about eight doses in a month.
A cautious first dose to gauge nausea before moving up. Taken about 45 minutes before intimacy.
The common range once tolerated. The approved Vyleesi dose of 1.75 mg sits here. Max one dose per 24 hours.
Cycling and timing.
PT-141 does not really cycle the way a recovery peptide does, because it is not run continuously. It is taken as-needed, before intimacy, so the relevant limits are per-dose and per-month rather than a weeks-on, weeks-off block.
The reason the ceilings matter is blood pressure. PT-141 transiently raises blood pressure after each dose, so spacing doses out and not exceeding the daily and monthly limits is the cautious, widely followed approach.
- One dose per 24 hours at most, taken about 45 minutes before intimacy.
- Around eight doses a month is the common ceiling, mirroring the approved label.
- Mind your blood pressure. If you have any cardiovascular concern, this is a conversation for a licensed provider before you start, not after.
Stacking PT-141.
PT-141 is usually run on its own, before intimacy. When people do combine it, the pairings are about layering desire with connection or blood flow.
Desire & connection
PT-141 drives desire centrally, while oxytocin is the bonding and closeness peptide. People pair them ahead of intimacy hoping to layer arousal with emotional connection. This is investigational, with little controlled human data behind it.
View stack →Desire plus blood flow
Some men combine the central desire effect of PT-141 with a PDE5 inhibitor that works on blood flow. Because both can shift blood pressure, this is strictly a provider conversation, not something to improvise.
View stack →See full recipes, dosing, and how people run them on the stacks page.
Side effects and safety.
In the reports we see, and in the trials behind the approved drug, PT-141 has a fairly well-characterized side effect profile. The ones people mention most often are:
- Nausea, by far the most common, reported by roughly 40 percent of users, usually with the first dose or two and often mild.
- Flushing, a warm, red feeling in the face, reported by around a fifth of users.
- Headache, common and usually mild.
- Injection-site reactions, a little redness or a small bump, which is why rotating sites matters.
- Skin darkening (hyperpigmentation), in a small share of users, sometimes on the face or gums, usually but not always reversible.
Who should be cautious.
Some people have clear reasons to be extra careful, or to avoid PT-141 entirely until they have spoken with a licensed provider.
- Heart disease or uncontrolled high blood pressure. Because PT-141 raises blood pressure after a dose, this is a hard avoid until a provider clears you. This is the single most important caution.
- Pregnant or breastfeeding. There is no safety data here, so this is a hard avoid.
- A history of skin cancer or many moles. Melanocortin peptides act on pigment cells, so caution is widely advised. This is a dermatologist conversation.
- Anyone on other medications, especially blood pressure drugs or PDE5 inhibitors like tadalafil. Talk to your provider first about how they interact.
And the universal one: whoever you are, talk to a licensed healthcare provider before starting PT-141. This guide is educational, not a substitute for personalized medical advice.
Where to buy it safely.
This is where a lot of beginners get burned, because peptide quality varies wildly between vendors and the cheapest vial is not always the real deal. Our honest take: do not shop on price alone, shop on price plus independent lab data.
- Compare vendors side by side. Price ranges are wide, and the difference between the lowest and highest listing can be large for the exact same compound.
- Look for recent third-party lab tests. The gold standard the community looks for is a recent Janoshik certificate of analysis showing purity for the batch you are actually buying.
- Favor recent COAs. An old lab result on a different batch tells you little. The fresher the test, the more it means.
- Be skeptical of suspiciously cheap listings with no testing behind them.
That is exactly the comparison we put together. On our PT-141 product page you can compare vendor prices, see which batches have public lab data, and view the grades we assign from that data. From there you can head to the buy page to line up your options.
Questions, answered straight.
Is PT-141 legal?
The active ingredient, bremelanotide, is FDA-approved as the prescription drug Vyleesi for premenopausal women with low sexual desire. The research vials we compare are not that product and are sold strictly for research use only, not as a medicine. Rules vary by country, so check what applies where you are.
Is PT-141 the same as Vyleesi?
It is the same molecule, bremelanotide. Vyleesi is the FDA-approved, manufactured, dose-controlled pen. The research-grade vial is the same compound sold for laboratory use only, without that approval or quality guarantee, which is why lab testing matters.
How is it different from Viagra?
Viagra and Cialis are PDE5 inhibitors that act on blood flow. PT-141 acts in the brain on melanocortin receptors to raise desire itself. That is why it is studied for low libido rather than purely mechanical function, and why it applies to both men and women.
How long before it works, and how long does it last?
People typically feel effects within about 45 minutes to two hours of a subcutaneous dose, lasting several hours. It is taken before intimacy on an as-needed basis, not on a daily schedule.
Why do people warn about blood pressure?
PT-141 transiently raises blood pressure after each dose. For most healthy users this is mild and short-lived, but for anyone with heart disease or uncontrolled hypertension it is a real concern, and a reason to talk to a provider before using it at all.